Research map: Safety of glucagon-like peptide-1 receptor agonists in neuroendocrine neoplasms

Back to the article

Papers in this map

  1. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. · Gang Xu · 1999 · 1214 citations · Cited by this paper
  2. Mid-pregnancy serum chemerin levels predict persistence of postpartum hypertension in patients with polycystic ovary syndrome · 2026 · Related
  3. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms · Guido Rindi · 2022 · 1032 citations · Cited by this paper
  4. Integrated Clinical–Genetic–Pathological Analysis Expands the Phenotypic and Molecular Spectrum of PPNAD Across Carney Complex and Isolated Forms · 2026 · Related
  5. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy · Zhikai Zheng · 2024 · 982 citations · Cited by this paper
  6. Changes in serum TSH across the adult lifespan: 22-year follow-up of the HUNT Study · 2026 · Related
  7. Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies · Michael R. Elashoff · 2011 · 949 citations · Cited by this paper
  8. Independent clonal evolution in primary pigmented nodular adrenocortical disease: a single-patient multi-omics study · 2026 · Related
  9. Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation · Lotte Bjerre Knudsen · 2010 · 663 citations · Cited by this paper
  10. Baseline biochemical evaluation for etiologic differentiation in ACTH-dependent Cushing’s syndrome: machine learning and composite score analysis in a multicenter cohort of 566 patients. · 2026 · Related
  11. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting · Jean Claude Reubi · 2003 · 592 citations · Cited by this paper
  12. From concept to protocol: iterative approach of a target trial emulation on GnRH analog safety in transgender and gender diverse youth · 2026 · Related
  13. GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting · Mira Korner · 2007 · 474 citations · Cited by this paper
  14. Magnesium as an endocrine modulator: physiological roles, clinical evidence, and therapeutic perspectives · 2026 · Related
  15. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors · Alexandra E. Butler · 2013 · 457 citations · Cited by this paper
  16. Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment · 2026 · Related
  17. Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits · Daniel J. Drucker · 2010 · 315 citations · Cited by this paper
  18. Targeted proteomics reveals novel biomarkers of disease activity and inflammation in acromegaly · 2026 · Related
  19. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer · Julien Bezin · 2022 · 313 citations · Cited by this paper
  20. Variable GLP-1 receptor expression across diverse neuroendocrine neoplasms: implications for incretin therapies · 2025 · Related
  21. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study · Emanuel Christ · 2013 · 188 citations · Cited by this paper
  22. Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland · Belinda Gier · 2011 · 155 citations · Cited by this paper
  23. Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials · Weiting Hu · 2022 · 118 citations · Cited by this paper
  24. Glucagon-like-peptide-1 receptor expression in normal and diseased human thyroid and pancreas · Beatrice Waser · 2014 · 117 citations · Cited by this paper
  25. GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS · Zheng Yang · 2022 · 117 citations · Cited by this paper
  26. Glucagon‐like peptide‐1 receptor agonists and risk of thyroid cancer: A systematic review and meta‐analysis of randomized controlled trials · Giovanni Antonio Silverii · 2023 · 108 citations · Cited by this paper
  27. Glucagon-like peptide 1 agonists and the development and growth of pancreatic β-cells · James F. List · 2004 · 94 citations · Cited by this paper
  28. Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis · Lana Catani Ferreira Pinto · 2019 · 85 citations · Cited by this paper
  29. Incretin Receptors in Non-Neoplastic and Neoplastic Thyroid C Cells in Rodents and Humans: Relevance for Incretin-Based Diabetes Therapy · Beatrice Waser · 2011 · 81 citations · Cited by this paper
  30. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1—Results From the Dutch MEN1 Study Group · Carolina R C Pieterman · 2017 · 79 citations · Cited by this paper
  31. Expression of glucagon‐like peptide 1 receptor in a murine C cell line Regulation of calcitonin gene by glucagon‐like peptide 1 · Y. Lamari · 1996 · 73 citations · Cited by this paper
  32. GLP1 and cancer: friend or foe? · Roman Vangoitsenhoven · 2012 · 73 citations · Cited by this paper
  33. Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study · Sarah A. Baxter · 2025 · 73 citations · Cited by this paper
  34. How glucagon-like peptide 1 receptor agonists work · Christine Rode Andreasen · 2021 · 72 citations · Cited by this paper
  35. Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications · Meike Körner · 2012 · 68 citations · Cited by this paper
  36. Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm · Sjoerd Nell · 2017 · 67 citations · Cited by this paper
  37. Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies · Susan Bonner‐Weir · 2014 · 54 citations · Cited by this paper
  38. Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: a meta-analysis · Mingxia Li · 2024 · 54 citations · Cited by this paper
  39. The incretin system ABCs in obesity and diabetes – novel therapeutic strategies for weight loss and beyond · A. L. João · 2016 · 45 citations · Cited by this paper

Source: OpenAlex (CC0)